Swiss Re, the world's second-largest reinsurer, may not be a smart investment choice despite favorable business conditions.

Weight-loss drugs could be a boon for insurers, but it is too soon to tell whether the industry will be transformed, the head ...

Swiss Re said it expects its net profit for 2025 to top this year’s expected result and issued dividend-growth guidance. The ...

Swiss Re is targeting a group net income of more than $4.4bn for 2025 and has maintained its multi-year equity target of more ...

Global reinsurance company Swiss Re said today that its third-party capital markets focused Alternative Capital Partners (ACP ...

The study compared insurance liability claims against Waymo to those brought against human drivers, based on Swiss Re’s data from over 500,000 claims and over 200 billion miles of exposure. Compared ...

Swiss reinsurer Swiss Re on Friday said it is targeting net income of $4.4 billion for 2025, compared to a mean net income estimate of $4.42 billion for 2025 provided by LSEG.

Liability claims in the US have risen by 57% over the past decade, with "nuclear verdicts" – jury awards exceeding US$10 ...

Swiss Re AG, Tokio Marine Holdings Inc., AXIS Capital Holdings Ltd and AXA SA are among providers of $3 billion in ...

The market should expect Swiss Re to continue building out its capabilities across insurance-linked securities (ILS) and ...

Weight-loss drugs could be a boon for insurers, but it is too soon to tell whether the industry will be transformed, the head of Swiss Re’s life and health reinsurance arm said. The market for ...